Journal of Diabetes Science and Technology (DST) is a bi-monthly, peer-reviewed scientific e-journal published by the Diabetes Technology Society, a non-profit organization. Our purpose is to promote the development and adoption of new products to help people with diabetes.
JDST covers all aspects of diabetes technology including: glucose monitoring; insulin and metabolic peptide delivery; the artificial and bioartificial pancreas, telemedicine; software for modeling; physiologic monitoring; technology for managing obesity; diagnostic tests of glycation; and the use of bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors and actuators to be applied to diabetes. Articles in DST will cover both basic research and clinical applications of technologies being developed to help people with diabetes.
JDST’s Editors, Editorial Board, Clinical Advisory Board, and staff aim to provide members of the diabetes technology community with information about the latest scientific and medical advances, as well as news of professional meetings and business developments in the field of diabetes technology. The importance of diabetes technology is increasing for the 200 million diabetes patients worldwide. JDST is a virtual meeting place for members of the diabetes technology community who: believe that technology can deliver great benefits to people with diabetes; want to read about what their peers are doing; and want to communicate with each other via Letters to the Editor, a type of format which will facilitate quick responses to posted letters.
JDST publishes Original Articles, Review Articles, Commentary Articles, Analysis Articles, Letters to the Editor, Proceedings of Diabetes Meetings, and regular columns devoted to business developments and the scientific and medical literature. The journal website provides the latest news stories and timely references from the medical literature.
JDST is the only journal that publishes the proceedings of the Diabetes Technology Meeting and the Clinical Diabetes Technology Meeting, as well as other diabetes meetings.
Those who subscribe to this electronic journal will have complete access to our News Section which includes the latest developments in research and business, plus important government announcements.
We at JDST hope you will find this journal informative, provocative, and even entertaining.
|David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE||Mills-Peninsula Medical Center, San Mateo, California, USA|
|Lutz Heinemann, PhD||Science & Co. Dusseldorf, Germany|
|Claudio Cobelli, PhD||University of Padova, Italy|
|Gerold M. Grodsky, PhD||University of California at San Francisco, USA|
|Boris Kovatchev, PhD||University of Virginia, USA|
|Bijan Najafi, PhD||Baylor College of Medicine, USA|
|Annamarie Sucher-Jones||Diabetes Technology Society, USA|
|Kevin Nguyen||Diabetes Technology Society, USA|
|Mark A. Arnold, PhD||University of Iowa, USA|
|Eirik Arsand, PhD||Norwegian Centre for Integrated Care and Telemedicine, Norway|
|Katharine Barnard-Kelly, PhD||BHR Ltd, Portsmouth, Hampshire, UK|
|Yael Barr, MD||NASA Johnson Space Center, USA|
|Riccardo Bellazzi, PhD||University of Pavia, Italy|
|B. Wayne Bequette, PhD||Rensselaer Polytechnic Institute, USA|
|Richard N. Bergman, PhD||Cedars-Sinai Medical Center, USA|
|Robert D. Burk, MD||Albert Einstein College of Medicine, USA|
|Jessica R. Castle, MD||Oregon Health & Science University, Portland, OR, USA|
|George Cembrowski, MD, PhD||University of Alberta, Canada|
|Geoffrey Chase, PhD||University of Canterbury, New Zealand|
|Kong Chen, PhD||NIDDK, National Institutes of Health, USA|
|Chiara Dalla Man, PhD||University of Padova, Italy|
|Erik Dutson, MD||University of California Los Angeles, USA|
|Niels Ejskaer, MD, PhD||Aalborg University Hospital, North Jutland, Denmark|
|G. Alexander Fleming, MD||Kinexum, USA|
|Thomas Forst, MD||University of Mainz, Germany|
|Karl E. Friedl, PhD||University of California at San Francisco, USA|
|Brian Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas)||The Queen's Medical Research Institute, University of Edinburgh, UK|
|Robert Gabbay, MD, PhD||American Diabetes Association, Boston, Massachusetts, USA|
|Michael S. German, MD||University of California at San Francisco, San Francisco, USA|
|Barry H. Ginsberg, MD, PhD||Diabetes Technology Consultants, Arlington, Virginia, USA|
|Andrei Gribok, PhD||United States Department of Agriculture, USA|
|Alberto Gutierrez, PhD||NDA Partners LLC, USA|
|Jeffrey I. Joseph, DO||Thomas Jefferson University, USA|
|Robert Langer, ScD||Massachusetts Institute of Technology, USA|
|Courtney H. Lias, PhD||Food and Drug Administration, Silver Spring, MD, USA|
|Dorian Liepmann, PhD||University of California at Berkeley, USA|
|Randie R. Little, PhD||University of Missouri, USA|
|Boris Mankovsky, MD||National Medical Academy for Postgraduate Education, Ukraine|
|Chhavi Mehta, M.D.||Palo Alto Medical Foundation, USA|
|Sultan Ayoub Meo, MBBS, M Med Ed, PhD, FRCP||College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia|
|V. Mohan, MD, FRCP, PhD, DSc, FNASc||Madras Diabetes Research Foundation, India|
|Shelagh Mulvaney, PhD||Vanderbilt University, USA|
|Danny Petrasek, MD, PhD||California Institute of Technology, USA|
|John Pickup, MD, PhD||Guy’s King’s & St. Thomas’ School of Medicine, UK|
|Leonard Pogach, MD||VA New Jersey Healthcare System, USA|
|Bruce Quinn, MD, JD||Bruce Quinn Associaties LLC, Los Angeles and Palo Alto, California, USA|
|Sohi Rastegar, PhD||National Science Foundation, USA|
|David Rodbard, MD||Biomedical Informatics Consultants LLC, Potomac, Maryland, USA|
|Jane Jeffrie Seley, DNP, MPH, MSN, BC-ADM, CDE||New York Presbyterian/Weill Cornell, USA|
|James Shapiro, MD, PhD, FRCS(Eng), FRCSC, MSM, FCAHS||University of Alberta, Edmonton, Canada|
|Koji Sode, PhD||The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA|
|Jeffrey Sutton, MD, PhD||Baylor College of Medicine Houston, Texas, USA|
|Mark True, MD||San Antonio Uniformed Services Health Education Consortium, Fort Sam Houston, Texas, USA|
|Elissa R. Weitzman, ScD, Msc||Harvard Medical School, Boston Children’s Hospital, USA|
|Darrell Wilson, MD||Stanford University, USA|
Guidelines for Submitting a Manuscript
After reading the guidelines, please submit to the manuscript central site.
All authors need to add their ORCID iDs in Manuscript Central prior to acceptance in order for the IDs to be published on the final article, if accepted. If your manuscript is accepted for publication, you will not be able to add an ORCID iD after the manuscript is sent to our production team.
JDST authors have the option to make their articles open access via SAGE Choice for $3,000. Learn more about SAGE Choice
JDST authors may fast track their articles to publication by paying the journal’s Fast Track fee of $3,000. Please contact our journal staff if you are interested in the Fast Track option upon submission.
Topics of Interest
Journal of Diabetes Science and Technology (DST) welcomes the submission of manuscripts with accompanying figures and tables whose topics relate to the study and treatment of diabetes:
- Glucose monitoring
- Insulin and metabolic peptide delivery
- Artificial and bioartificial pancreas
- Information technology
- Software for modeling
- Physiologic monitoring
- Technology for managing obesity
- Diagnostic tests of glycation
- Personalized medicine for diabetes, including pharmacogenomics and biomarkers
- Technology for improving adherence to therapy
- Use of bioengineered tools such as
- New biomaterials
- Nanotechnology in the development of sensors and actuators
Journal of Diabetes Science and Technology features articles that cover basic research and clinical applications of technology that are being developed to help people with diabetes. The journal is also committed to delivering high quality, fast peer-review for your paper.
"Thanks for your fast turnaround. This is actually one of the main reasons why I choose DST instead of other journals"
- Anonymous author
If you or your funder wish your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.